Regulatory Affairs Syndicator

SOUTH SAN FRANCISCO, Calif., Feb. 28 /PRNewswire-FirstCall/ — Genentech, ( Nachrichten ) Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for the use of Lucentis(TM) (ranibizumab) in the treatment of neovascular wet age-related macular degeneration (AMD). As part of the BLA filing, Genentech requested and has been granted

Morgan Stanley reiterated an “underweight” rating on the specialty drug company.

Callisto drug works in carcinoid cancerUnited Press International - 10 hours ago… product fulfills an "unmet medical need," which could qualify it for speeded review — within six months — under the Food and Drug Administration's …

Morgan Stanley reiterated an “underweight” rating on the specialty drug company.

HARRISBURG - ‘ The Department of Environmental Protection today said it has fined Geisinger Medical Group $900,000 for not performing required equipment testing and falsifying records at its Lock Haven clinic, …

Washington (AP) - Federal regulators approved the first antidepressant skin patch on Tuesday, providing a different way to administer a drug already used by Parkinson’s disease patients. The Food and Drug Administration approved the selegiline transdermal patch, agency spokeswoman Susan Cruzan said.

WASHINGTON (Reuters) - The first skin patch to treat major depression in adults has won final approval to be sold in the United States, the U.S. Food and Drug Administration said on Tuesday.

WASHINGTON (Reuters) - The first skin patch to treat major depression in adults has won final approval to be sold in the United States, the U.S. Food and Drug Administration said on Tuesday.

The first skin patch to treat major depression in adults has won final approval to be sold in the United States, the U.S. Food and Drug Administration said on Tuesday.

Federal regulators approved the first antidepressant skin patch on Tuesday, providing a different way to administer a drug already used by Parkinson’s disease patients. The Food and Drug Administration approved the selegiline transdermal patch, agency…

WASHINGTON, D.C. - Federal regulators approved the first antidepressant skin patch on Tuesday, providing a different way to administer a drug already used by Parkinson’s disease patients.

The goal of the response plan is to enhance the protection of the nation’s agricultural industry and food security through prevention, detection, response, and recovery.

The goal of the response plan is to enhance the protection of the nation’s agricultural industry and food security through prevention, detection, response, and recovery.

WASHINGTON A research group says it plans to submit a petition to the Food and Drug Administration, seeking a federal ban on painkillers it says have been associated with the deaths of more than 21-hundred people between 1981 and 1999.